AEON Biopharma Inc - Class A
Exchange: NYSE MKTSector: HealthcareIndustry: Biotechnology
Priveterra Acquisition Corp - Class A
Did you know?
Price sits at 49% of its 52-week range.
Current Price
$0.89
-9.16%Profile
Valuation (TTM)
Market Cap$10.52M
P/E-0.27
EV—
P/B—
Shares Out11.84M
P/Sales—
Revenue$0.00
EV/EBITDA—
AEON Biopharma Inc - Class A (AEON) Stock Analysis
Market Cap$10.52M
Current Price$0.89
P/E Ratio-0.27
Forward P/E—
PEG Ratio0.00
EPS$-3.95
Book Value$-4.65
P/B Ratio—
AEON Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Debt: 32M
Revenue
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Net Income
—
FY20
—
FY21
—
FY22
—
FY23
42M
FY24
—
FY25
AEON 52-Week Range
$0.40
$1.40
50-Day MA: $1.10200-Day MA: $0.93
Did you know?
Price sits at 49% of its 52-week range.
AEON Biopharma Inc - Class A (AEON) Financial Summary
AEON Biopharma Inc - Class A (AEON) is a Healthcare company in the Biotechnology industry, listed on NYSE MKT. The stock currently trades at $0.89 with a market capitalization of $10.52M.
Key valuation metrics include a P/E ratio of -0.27, and EPS of $-3.95..
AEON Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $10.52M |
| P/E Ratio | -0.27 |
| EPS | $-3.95 |
AEON Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY20 | $0.00 | $-3588.00 |
| FY21 | $0.00 | $-55.64M |
| FY22 | $0.00 | $-52.56M |
| FY23 | $0.00 | $-323.95M |
| FY24 | $0.00 | $42.01M |
| FY25 | $0.00 | $-39.22M |
About AEON Biopharma Inc - Class A
Priveterra Acquisition Corp - Class A
AEON Free Cash Flow
AEON Biopharma Inc - Class A generated $-17.31M in trailing twelve-month free cash flow, representing an FCF yield of -164.53%. This low FCF yield may reflect heavy reinvestment or growth spending.
AEON Shares Outstanding
AEON Biopharma Inc - Class A has 0.01 billion shares outstanding at a share price of $0.89, giving it a market capitalization of $10.52M.